{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1382825893677944962.json","@type":"Researcher","foaf:Person":[{"foaf:name":[{"@value":"Olivier A. Bernard"}],"foaf:familyName":[{"@value":"Bernard"}],"foaf:givenName":[{"@value":"Olivier A."}]}],"career":[{"institution":{"notation":[{"@value":"From the Division of Hematology/Oncology, Brigham and Women's Hospital and Division of Oncology, Dana-Farber Cancer Institute, Boston, MA; the U 301 de L'Institut National de la Santé et de la Recherche Medicale (INSERM) and SD 401 No. 301 CNRS, Institut de Genetique Moleculaire, Paris, France; and the Howard Hughes Medical Institute, Harvard Medical School, Boston, MA."}]}}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1362825893677944960","@type":"Article","productIdentifier":[{"@type":"DOI","@value":"10.1182/blood.v91.12.4419"},{"@type":"URI","@value":"http://ashpublications.org/blood/article-pdf/91/12/4419/1644929/4419.pdf"}],"notation":[{"@value":"Fusion of Huntingtin Interacting Protein 1 to Platelet-Derived Growth Factor β Receptor (PDGFβR) in Chronic Myelomonocytic Leukemia With t(5;7)(q33;q11.2)"}],"relation":[{"type":"creator"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1182/blood.v91.12.4419_1ejLgnkdslbjE1tZkHArwxPK7Xx"}]}